Stuart E. Starr

8.7k total citations
140 papers, 6.5k citations indexed

About

Stuart E. Starr is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Stuart E. Starr has authored 140 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Epidemiology, 54 papers in Immunology and 36 papers in Virology. Recurrent topics in Stuart E. Starr's work include Cytomegalovirus and herpesvirus research (62 papers), Herpesvirus Infections and Treatments (53 papers) and Immune Cell Function and Interaction (34 papers). Stuart E. Starr is often cited by papers focused on Cytomegalovirus and herpesvirus research (62 papers), Herpesvirus Infections and Treatments (53 papers) and Immune Cell Function and Interaction (34 papers). Stuart E. Starr collaborates with scholars based in United States, France and Puerto Rico. Stuart E. Starr's co-authors include Stanley A. Plotkin, Giorgio Trinchieri, B Perussia, André J. Nahmias, Allan M. Arbeter, Jihed Chehimi, S. A. Plotkin, Harvey M. Friedman, V Fanning and Samuel R. Abraham and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Stuart E. Starr

140 papers receiving 6.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stuart E. Starr 4.1k 2.1k 1.7k 1.2k 601 140 6.5k
Adriana Weinberg 4.3k 1.0× 1.5k 0.7× 1.2k 0.7× 879 0.7× 453 0.8× 234 6.3k
D. Scott Schmid 5.2k 1.2× 1.0k 0.5× 1.2k 0.7× 1.2k 1.0× 1.2k 2.0× 148 6.8k
Anthony Hayward 2.5k 0.6× 2.1k 1.0× 452 0.3× 547 0.4× 725 1.2× 155 5.3k
Gerald V. Quinnan 2.7k 0.7× 2.3k 1.1× 1.3k 0.8× 2.1k 1.7× 269 0.4× 116 5.6k
Yvonne J. Bryson 2.8k 0.7× 1.5k 0.7× 2.8k 1.7× 2.7k 2.2× 189 0.3× 143 6.3k
Amalia Magaret 4.4k 1.1× 899 0.4× 1.6k 0.9× 979 0.8× 235 0.4× 145 6.2k
Anton M. van Loon 4.9k 1.2× 713 0.3× 2.9k 1.7× 279 0.2× 475 0.8× 184 7.7k
Monto Ho 3.2k 0.8× 1.0k 0.5× 2.3k 1.4× 356 0.3× 204 0.3× 114 6.6k
Thomas H. Weller 3.4k 0.8× 555 0.3× 1.0k 0.6× 285 0.2× 991 1.6× 99 5.2k
Massimo Clementi 3.7k 0.9× 972 0.5× 2.8k 1.6× 1.9k 1.5× 162 0.3× 325 9.8k

Countries citing papers authored by Stuart E. Starr

Since Specialization
Citations

This map shows the geographic impact of Stuart E. Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Starr more than expected).

Fields of papers citing papers by Stuart E. Starr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart E. Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Starr. The network helps show where Stuart E. Starr may publish in the future.

Co-authorship network of co-authors of Stuart E. Starr

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart E. Starr. A scholar is included among the top collaborators of Stuart E. Starr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart E. Starr. Stuart E. Starr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Starr, Stuart E., Courtney V. Fletcher, Stephen A. Spector, et al.. (2002). Efavirenz liquid formulation in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 21(7). 659–663. 26 indexed citations
2.
Starr, Stuart E., Moussa Sarr, Donald E. Campbell, Craig M. Wilson, & Steven D. Douglas. (2002). Increased Proliferation within T Lymphocyte Subsets of HIV-Infected Adolescents. AIDS Research and Human Retroviruses. 18(17). 1301–1310. 8 indexed citations
3.
Hodinka, Richard L., et al.. (2001). Respiratory Syncytial Virus: An Association with Severe Asthma Exacerbations in Children of All Ages. Pediatric Asthma Allergy & Immunology. 15(2). 69–75. 5 indexed citations
4.
Merrill, Jeffrey D., Yuan Li, Changjiang Guo, et al.. (2001). HIV-1 Infection of Placental Cord Blood Monocyte-Derived Dendritic Cells. Journal of Hematotherapy & Stem Cell Research. 10(5). 609–620. 3 indexed citations
5.
Douglas, Steven D., Stephen Durako, Nancy B. Tustin, et al.. (2001). Natural Killer Cell Enumeration and Function in HIV-Infected and High-Risk Uninfected Adolescents. AIDS Research and Human Retroviruses. 17(6). 543–552. 31 indexed citations
6.
Starr, Stuart E., Kathleen E. Sullivan, Donald E. Campbell, et al.. (2000). Rapid Method for Determining the Rate of DNA Synthesis and Cellular Proliferation. Analytical Biochemistry. 278(2). 198–205. 11 indexed citations
7.
Rutstein, Richard M. & Stuart E. Starr. (1997). Immunizing the HIV-Infected Child. AIDS Patient Care and STDs. 11(3). 149–160. 2 indexed citations
8.
Chehimi, Jihed, Stuart E. Starr, Ian Frank, et al.. (1994). Impaired interleukin 12 production in human immunodeficiency virus-infected patients.. The Journal of Experimental Medicine. 179(4). 1361–1366. 368 indexed citations
9.
Gruber, William C., Gregory A. Storch, Gail J. Demmler, et al.. (1993). Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clinical Pharmacology & Therapeutics. 53(1). 15–21. 70 indexed citations
10.
11.
Chehimi, Jihed, Stuart E. Starr, Ian Frank, et al.. (1992). Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.. The Journal of Experimental Medicine. 175(3). 789–796. 163 indexed citations
12.
Plotkin, Stanley A., Stuart E. Starr, Harvey M. Friedman, & Éva Gönczöl. (1987). COMPARISON OF VACCINE-INDUCED AND NATURAL IMMUNITY TO HUMAN CYTOMEGALOVIRUS (CMV). Pediatric Research. 21(4). 332A–332A. 1 indexed citations
13.
Perussia, B, et al.. (1986). Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.. The Journal of Experimental Medicine. 164(1). 180–195. 88 indexed citations
14.
Arbeter, Allan M., Stuart E. Starr, & Stanley A. Plotkin. (1986). Varicella Vaccine Studies in Healthy Children and Adults. PEDIATRICS. 78(4). 748–756. 154 indexed citations
15.
Plotkin, Stanley A., et al.. (1985). Los peores malos. PubMed. 61 Suppl 4(127). 155–52. 5 indexed citations
16.
Starr, Stuart E.. (1985). Antimicrobial therapy of bacterial sepsis in the newborn infant. The Journal of Pediatrics. 106(6). 1043–1048. 18 indexed citations
17.
Plotkin, Stanley A., S. Michelson, Charles A. Alford, et al.. (1984). The pathogenesis and prevention of human cytomegalovirus infection. The Pediatric Infectious Disease Journal. 3(1). 67–74. 7 indexed citations
18.
Ihara, Toshiaki, Stuart E. Starr, Allan M. Arbeter, & Stanley A. Plotkin. (1983). Effects of Interferon on Natural Killing and Antibody-Dependent Cellular Cytotoxicity Against Varicella-Zoster Virus-Infected and Uninfected Target Cells. Journal of Interferon Research. 3(3). 263–269. 7 indexed citations
19.
Fleisher, Gary, et al.. (1982). A non-X-linked syndrome with susceptibility to severe epstein-barr virus infections. The Journal of Pediatrics. 100(5). 727–730. 122 indexed citations
20.
Arbeter, Allan M., Stuart E. Starr, Robert E. Weibel, & Stanley A. Plotkin. (1982). Live attenuated varicella vaccine: Immunization of healthy children with the OKA strain. The Journal of Pediatrics. 100(6). 886–893. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Weinberg Breakdown of academic impact, for papers by D. Scott Schmid Breakdown of academic impact, for papers by Anthony Hayward Breakdown of academic impact, for papers by Gerald V. Quinnan Breakdown of academic impact, for papers by Yvonne J. Bryson Breakdown of academic impact, for papers by Amalia Magaret Breakdown of academic impact, for papers by Anton M. van Loon Breakdown of academic impact, for papers by Monto Ho Breakdown of academic impact, for papers by Thomas H. Weller Breakdown of academic impact, for papers by Massimo Clementi
Rankless by CCL
2026